JNJ - JOHNSON & JOHNSON
148.44
-5.700 -3.840%
Share volume: 10,313,908
Last Updated: 05-13-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$154.14
-5.70
-0.04%
View ratios
| Fiscal Date | 07-02-2023 | 10-01-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-29-2024 | 12-29-2024 | 03-30-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 07-31-2023 | 10-27-2023 | 02-13-2025 | 05-01-2024 | 07-25-2024 | 10-23-2024 | 02-13-2025 | 04-23-2025 | |
| Assets | |||||||||
| Total Assets | 191.686 B | 166.061 B | 167.558 B | 171.966 B | 181.088 B | 178.287 B | 180.104 B | 193.671 B | |
| Current Assets | 60.567 B | 53.703 B | 53.495 B | 57.002 B | 57.817 B | 53.249 B | 55.893 B | 71.551 B | |
| Inventories | 12.888 B | 11.198 B | 11.181 B | 11.383 B | 12.169 B | 12.603 B | 12.444 B | 12.659 B | |
| Other Current Assets | 2.397 B | 4.196 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 2.397 B | 4.196 B | 1.068 B | 745.000 M | 597.000 M | 317.000 M | 417.000 M | 307.000 M | |
| Total Receivables | 16.777 B | 14.798 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 28.505 B | 23.511 B | 21.859 B | 25.473 B | 24.878 B | 19.980 B | 24.105 B | 38.474 B | |
| Total Non-current Assets | 131.119 B | 112.358 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 20.576 B | 18.821 B | 19.898 B | 19.632 B | 19.748 B | 20.479 B | 20.518 B | 20.871 B | |
| Other Assets | 10.078 B | 13.133 B | 94.165 B | 95.332 B | 103.523 B | 104.559 B | 103.693 B | 101.249 B | |
| Intangible Assets | 46.246 B | 35.021 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 45.440 B | 36.124 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 191.686 B | 166.061 B | 167.558 B | 171.966 B | 181.088 B | 178.287 B | 180.104 B | 193.671 B | |
| Total liabilities | 116.537 B | 94.833 B | 98.784 B | 101.946 B | 109.550 B | 108.129 B | 108.614 B | 115.562 B | |
| Total current liabilities | 54.170 B | 44.370 B | 46.282 B | 48.725 B | 53.933 B | 51.759 B | 50.321 B | 56.903 B | |
| Accounts Payable | 10.443 B | 8.355 B | 9.632 B | 8.174 B | 8.848 B | 8.954 B | 10.311 B | 9.545 B | |
| Other liabilities | 23.579 B | 21.789 B | 13.398 B | 15.067 B | 14.086 B | 14.923 B | 17.549 B | 10.435 B | |
| Current long term debt | 11.701 B | 3.870 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 33.901 B | 26.051 B | 25.881 B | 25.082 B | 31.636 B | 31.289 B | 30.651 B | 38.355 B | |
| Other liabilities | 23.579 B | 21.789 B | 13.398 B | 15.067 B | 14.086 B | 14.923 B | 17.549 B | 10.435 B | |
| Minority interest | 1.260 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 75.149 B | 71.228 B | 68.774 B | 70.020 B | 71.538 B | 70.158 B | 71.490 B | 78.109 B | |
| Common stock | 2.598 B | 2.523 B | 3.120 B | 3.120 B | 3.120 B | 3.120 B | 3.120 B | 3.120 B | |
| Retained earnings | 129.381 B | 152.536 B | 153.843 B | 153.378 B | 155.360 B | 155.179 B | 155.791 B | 162.635 B |
